
201 - 500 employees
Founded 2003
π Pharmaceuticals
𧬠Biotechnology
Pharmaceuticals β’ Biotechnology
Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company focused on discovering and developing switch-control kinase inhibitors to treat cancer. The company designs targeted small-molecule therapies that address tumor growth and mechanisms of drug resistance, advancing a pipeline that includes ripretinib, vimseltinib (ROMVIMZAβ’), tirabrutinib and several other candidates; ROMVIMZA received European Commission approval for tenosynovial giant cell tumor. Deciphera emphasizes patient-focused oncology research and, as of June 2024, is a member of ONO Pharma.
π₯ 2 minutes ago
Medical Science Liaison II serving as a field-based scientific expert within oncology. Building relationships with KOLs and delivering scientific insights while ensuring compliance and strategic alignment.
πΊπΈ United States β Remote
π΅ $192.8k - $264k / year
β° Full Time
π Senior
π΄ Lead
π¦ H1B Visa Sponsor